Cell Therapy Market by Therapy (Mesenchymal Stem Cell Therapy, Fibroblast Cell Therapy, Hematopoietic Stem Cell Therapy), Type, Application, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2029

Cell Therapy Market Size

The Cell Therapy market size was valued at $14.36 billion in 2023 and is projected to reach $42.25 billion by 2029, growing at a CAGR of 19.7% during the forecast period.

Cell Therapy Market Overview

Cell therapy refers to a type of medical treatment that involves the transplantation, infusion, or manipulation of cells to restore, replace, or enhance the function of damaged or diseased tissues or organs in the body. This innovative therapeutic approach harnesses the regenerative and healing properties of various types of cells, including stem cells, immune cells, or genetically modified cells, to target specific medical conditions or diseases. Cell therapy holds promise for treating a wide range of conditions, including cancer, autoimmune disorders, neurodegenerative diseases, cardiovascular diseases, and genetic disorders. Depending on the specific application, cell therapy may involve isolating and expanding a patient's own cells for autologous transplantation, or using cells derived from a donor or from laboratory cultures for allogeneic transplantation. The field of cell therapy is rapidly advancing, with ongoing research and clinical trials exploring new techniques, cell sources, and therapeutic applications, offering hope for improved treatments and potential cures for various medical conditions in the future.

Cell Therapy Market Dynamics

The market dynamics analyzed in this market research report encapsulate a multifaceted interplay of drivers and constraints that significantly shape the landscape of the Cell Therapy Market. The comprehensive analysis of both drivers and constraints enables a nuanced understanding of the market's dynamics, empowering businesses and stakeholders to make informed decisions in navigating the complexities of the market.

Cell Therapy Market Scope

The report “Global Cell Therapy Market: Industry Analysis, Opportunities and Forecast up to 2029” by Diligence Insights provides a detailed analysis of the present market and future outlook with market estimates and forecasts for all specified segments, encompassing both global and regional perspectives as outlined within the research framework. The study includes historical market data for the years 2021, 2022 and offers revenue estimations for 2023, and project forecasts spanning from 2024 to 2029. It places significant emphasis on the examination of market trends, key industry participants, supply chain developments, technological advancements, pivotal milestones, and prospective strategies. Comprehensive market assessments are carried out across major geographic regions, including North America, Europe, Asia Pacific, South America, and Middle East & Africa. As such, this report constitutes a valuable resource for current industry stakeholders, newcomers to the field, and potential investors.

The study offers an in-depth market analysis, drawing insights from industry experts across the value chain. A special focus has been made on 25 countries, including the United States, Canada, Mexico, the United Kingdom, Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa, among others. The market data has been meticulously collected through extensive primary interviews and comprehensive secondary research. Market size determination is rooted in the revenue generated from sales across all the specified segments and sub-segments as defined within the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Market Segmentation:

The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Global Cell Therapy Market by, Therapy

·        Mesenchymal Stem Cell Therapy

·        Fibroblast Cell Therapy

·        Hematopoietic Stem Cell Therapy

·        Other Therapies

Global Cell Therapy Market by, Type

·        Autologous

·        Allogeneic

Global Cell Therapy Market by, Application

·        Cardiovascular

·        Dermatology and Wounds

·        Malignancies

·        Musculoskeletal

·        Other Applications

Global Cell Therapy Market by, End User

·        Hospitals

·        Homecare

·        Specialty Clinics

Global Cell Therapy Market by, Geography

·        North America (The United States, Canada, Mexico), Market Estimates, Forecast & Opportunity Analysis.

·        Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Market Estimates, Forecast & Opportunity Analysis

·        Asia Pacific (China, Japan, India, South Korea, Australia, New Zealand, Rest of Asia Pacific), Market Estimates, Forecast & Opportunity Analysis

·        South America (Brazil, Argentina, Chile, Rest of South America), Market Estimates, Forecast & Opportunity Analysis

·        Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, Rest of Middle East & Africa), Market Estimates, Forecast & Opportunity Analysis.

Key Players Profiled in this Research Report include:

·        Abeona Cell Therapeutics

·        Allogene Therapeutics

·        Amgen

·        Bluebird Bio

·        Bristol Myers Squibb

·        Celyad Oncology

·        Gilead Sciences Inc.

·        Novartis AG

·        NuVasive

·        Verticel

What can be explored with this research report?

·        Understand global Cell Therapy Market analysis, trends, and forecast to 2029.

·        Understand analysis of the Cell Therapy Market structure by identifying various segments and sub-segments of the market.

·        Understand revenue forecast and strategic analysis concerning industry trends and contribution to the overall Cell Therapy Market.

·        Understand the revenue forecast of the Cell Therapy Market for North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

·        Identification of major market trends, factors driving, restraining, threatening, and providing opportunities for the Cell Therapy Market growth.

·        Analyzing opportunities by identification of high-growth segments/revenue pockets in the Cell Therapy Market.

·        Understand major player profiles in the Cell Therapy Market and analyze their business strategies.

·        Understand competitive developments such as joint ventures, alliances, mergers and acquisitions, and new product launches in the Cell Therapy Market.

Table Of Content

1 Market Introduction 
 1.1 Market Definition 
 1.2 Research Scope and Segmentation 
 1.3 Stakeholders 
 1.4 List of Abbreviations 
 
2 Executive Summary 
 
3 Research Methodology 
 3.1 Identification of Data 
 3.2 Evaluation of Market Dynamics 
 3.3 Collaboration of Data 
 3.4 Verification and Analysis 
 3.5 Research Approach 
 3.6 Data Sources and Assumptions 
 
4 Market Dynamics 
 4.1 Market Drivers 
 4.2 Market Restraints 
 4.3 Market Opportunities 
 4.4 Market Challenges 
 4.5 Impact of COVID-19 on the Cell Therapy Market 
 
5 Porter's Five Force Analysis 
 5.1 Bargaining Power of Suppliers 
 5.2 Bargaining Power of Buyers 
 5.3 Threat of New Entrants 
 5.4 Threat of Substitutes 
 5.5 Competitive Rivalry in the Market 
 
6 Global Cell Therapy Market by, Therapy 
 6.1 Overview 
 6.2 Mesenchymal Stem Cell Therapy 
 6.3 Fibroblast Cell Therapy 
 6.4 Hematopoietic Stem Cell Therapy 
 6.5 Other Therapies 
 
7 Global Cell Therapy Market by, Type 
 7.1 Overview 
 7.2 Autologous 
 7.3 Allogeneic 
 
8 Global Cell Therapy Market by, Application 
 8.1 Overview 
 8.2 Cardiovascular 
 8.3 Dermatology and Wounds 
 8.4 Malignancies 
 8.5 Musculoskeletal 
 8.6 Other Applications 
 
9 Global Cell Therapy Market by, End User 
 9.1 Overview 
 9.2 Hospitals 
 9.3 Homecare 
 9.4 Specialty Clinics 
 
10 Global Cell Therapy Market by, Geography 
 10.1 Overview 
 10.2 North America 
 10.2.1 US 
 10.2.2 Canada 
 10.2.3 Mexico 
 10.3 Europe 
 10.3.1 Germany 
 10.3.2 France 
 10.3.3 UK 
 10.3.4 Italy 
 10.3.5 Spain 
 10.3.6 Rest of Europe 
 10.4 Asia Pacific 
 10.4.1 China 
 10.4.2 Japan 
 10.4.3 India 
 10.4.4 South Korea 
 10.4.5 Australia 
 10.4.6 New Zealand 
 10.4.7 Rest of Asia Pacific 
 10.5 South America 
 10.5.1 Brazil 
 10.5.2 Argentina 
 10.5.3 Chile 
 10.5.4 Rest of South America 
 10.6 Middle East & Africa 
 10.6.1 UAE 
 10.6.2 Saudi Arabia 
 10.6.3 Qatar 
 10.6.4 Iran 
 10.6.5 South Africa 
 10.6.6 Rest of Middle East & Africa 
 
11 Key Developments 
 
12 Company Profiling 
 12.1 Abeona Cell Therapeutics  
 12.1.1 Business Overview 
 12.1.2 Product/Service Offering 
 12.1.3 Financial Overview 
 12.1.4 SWOT Analysis 
 12.1.5 Key Activities 
 12.2 Allogene Therapeutics 
 12.3 Amgen 
 12.4 Bluebird Bio 
 12.5 Bristol Myers Squibb 
 12.6 Celyad Oncology  
 12.7 Gilead Sciences Inc. 
 12.8 Novartis AG  
 12.9 NuVasive 
 12.10 Verticel